Molecular and Cellular Biology, July 1999, p. 4757-4765, Vol. 19, No. 7
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Department of Microbiology1 and Washington Regional Primate Research Center,2 University of Washington, Seattle, Washington 98195, and Department of Cancer Biology, Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio 441953
Received 17 December 1998/Returned for modification 8 February 1999/Accepted 28 April 1999
P58IPK is a tetratricopeptide repeat-containing
cochaperone that is involved in stress-activated cellular
pathways and that inhibits the activity of protein kinase PKR, a
primary mediator of the antiviral and
antiproliferative properties of interferon. To gain better insight into the molecular actions of P58IPK, we
generated NIH 3T3 cell lines expressing either wild-type P58IPK or a P58IPK deletion mutant,
TPR6,
that does not bind to or inhibit PKR. When treated with double-stranded
RNA (dsRNA),
TPR6-expressing cells exhibited a
significant increase in eukaryotic initiation factor 2
phosphorylation and NF-
B activation, indicating a functional PKR. In
contrast, both of these PKR-dependent events were blocked by the
overexpression of wild-type P58IPK. In addition, the
P58IPK cell line, but not the
TPR6 cell line, was
resistant to dsRNA-induced apoptosis. Together, these findings
demonstrate that P58IPK regulates dsRNA signaling pathways
by inhibiting multiple PKR-dependent functions. In contrast, both the
P58IPK and
TPR6 cell lines were resistant to tumor
necrosis factor alpha-induced apoptosis, suggesting that
P58IPK may function as a more general suppressor of
programmed cell death independently of its PKR-inhibitory properties.
In accordance with this hypothesis, although PKR remained active in
TPR6-expressing cells, the
TPR6 cell line displayed a transformed
phenotype and was tumorigenic in nude mice. Thus, the antiapoptotic
function of P58IPK may be an important factor in its
ability to malignantly transform cells.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|